Adaptive evolution of koala retrovirus transcription silencing and what it means for conservation

Abstract

Koala populations in Australia face a barrage of threats, chiefly, habitat degradation and the effects of climate change including drought and bushfire. Further, high rates of chlamydiosis, linked to koala retrovirus (KoRV) viral load, is a major contributing factor to northern population decline. However, recent work by Yu et al., (Cell, 2024) has provided a glimmer of hope: some koalas have evolved ‘adaptive genome immunity’, which is able to actively suppress endogenous KoRV transcription. A single KoRV-A provirus insertion within MAP4K4 gene's 3’ UTR is shown to be the trigger for production of sense and anti-sense piRNAs, and that MAP4K4 KoRV integration is linked to both a 20% reduction in proviral genome integrations and 10-fold reduction of KoRV transcription within male germline tissue. Here we discuss how this finding offers the potential to reduce koala disease burden and can be incorporated into conservation management to help save this iconic species.

Keywords

chlamydia / conservation / Koala / piRNA / retrovirus

References

[1] Gordon G, Hrdina F, Patterson R. Decline in the distribution of the koala Phascolarctos cinereus in Queensland. Aust Zool. 2006; 33(3): 345-358.

[2] Gonzalez-Astudillo V, Allavena R, McKinnon A, Larkin R, Henning J. Decline causes of Koalas in South East Queensland, Australia: a 17-year retrospective study of mortality and morbidity. Sci Rep. 2017; 7: 42587.

[3] Jackson M, White N, Giffard P, Timms P. Epizootiology of Chlamydia infections in two free-range koala populations. Vet Microbiol.1999; 65(4): 255-264.

[4] Blyton MDJ, Pyne M, Young P, Chappell K. Koala retrovirus load and non-A subtypes are associated with secondary disease among wild northern koalas. PLoS Pathog. 2022; 18(5): e1010513.

[5] Ishida Y, Zhao K, Greenwood AD, Roca AL. Proliferation of endogenous retroviruses in the early stages of a host germ line invasion. Mol Biol Evol. 2015; 32(1): 109-120.

[6] Sarker N, Fabijan J, Owen H, et al. Koala retrovirus viral load and disease burden in distinct northern and southern koala populations. Sci Rep.2020; 10(1): 263.

[7] Hashem MA, Maetani F, Kayesh MEH, et al. Transmission of Koala Retrovirus from Parent Koalas to a Joey in a Japanese Zoo. J Virol.2020; 94(11).

[8] Volkman HE, Stetson DB. The enemy within: endogenous retroelements and autoimmune disease. Nat Immunol. 2014; 15(5): 415-422.

[9] Geis FK, Goff SP. Silencing and Transcriptional Regulation of Endogenous Retroviruses: an overview. Viruses.2020; 12(8).

[10] Yu T, Koppetsch BS, Pagliarani S, Johnston S, Silverstein NJ, Luban J., et al. The piRNA Response to Retroviral Invasion of the Koala Genome. Cell.2019; 179(3): 632-643.e12.

[11] Yu T, Blyton M, Abajorga M, et al. Adaptive evolution of KoRV-A transcriptional silencing in wild koalas. Cell. 2025;188(8): 2081-2093.e16.

[12] Bock M, Stoye JP. Endogenous retroviruses and the human germline. Curr Opin Genet Dev.2000; 10(6): 651-655.

[13] Wildschutte JH, Williams ZH, Montesion M, Subramanian RP, Kidd JM, Coffin JM. Discovery of unfixed endogenous retrovirus insertions in diverse human populations. Proc Natl Acad Sci U S A.2016; 113(16): E2326-E2334.

[14] Roca AL, Nash WG, Menninger JC, Murphy WJ, O'Brien SJ. Insertional polymorphisms of endogenous feline leukemia viruses. J Virol.2005; 79(7): 3979-3986.

[15] Sistiaga-Poveda M, Larruskain A, Mateo-Abad M, Jugo BM. Lack of association between polymorphic copies of endogenous Jaagsiekte sheep retrovirus (enJSRVs) and Ovine Pulmonary Adenocarcinoma. Vet Microbiol.2016; 185: 49-55.

[16] Xue B, Sechi LA, Kelvin DJ. Human Endogenous Retrovirus K (HML-2) in Health and Disease. Front Microbiol.2020; 11: 1690.

[17] Robbins A, Hanger J, Jelocnik M, Quigley BL, Timms P. Koala immunogenetics and chlamydial strain type are more directly involved in chlamydial disease progression in koalas from two south east Queensland koala populations than koala retrovirus subtypes. Sci Rep.2020; 10(1): 15013.

RIGHTS & PERMISSIONS

2025 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.